Industry News Roundup
This article was originally published in The Tan Sheet
Speech supplement firm stifled; Botanical Adulterants Program guidance debuts; Fruitful supplements, app launch; Bulu partners with bug protein firm; Healthy Mama extends line; Unilever acquires P&G’s Camay; demand soars for prebiotic infant food supplement; Axiom adds facility, appoints medical board chief; Kefir national ads debut during Golden Globes; and direct selling veteran heads foru.
You may also be interested in...
Sodium phosphate laxatives linked to SAERs; FTC scrutinizes personalized supplement claims; NAD refers Xlear LLC to FTC; ChromaDex inks marketing deal with 5LINX; CVS launches vitamin sales, info hub on its website; Star Scientific shareholder suit proceeds.
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.